ELIANSH(SH:600836)2022-10-28 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥135,531,321.86, representing a decrease of 12.58% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥21,904,977.09, a decline of 137.81% year-on-year[4]. - The basic earnings per share for the year-to-date period was -¥0.073, reflecting a decrease of 137.82% compared to the previous year[5]. - Total revenue for the first three quarters of 2022 was CNY 365,042,947.64, a decrease of 37.9% compared to CNY 588,548,386.42 in the same period of 2021[30]. - Operating profit for the third quarter of 2022 was a loss of CNY 38,000,285.88, compared to a profit of CNY 161,523,924.00 in the same quarter of 2021[31]. - The net profit for Q3 2022 was -51,535,882.74 RMB, compared to a net profit of 129,232,190.48 RMB in Q3 2021, indicating a significant decline[32]. - The basic and diluted earnings per share for Q3 2022 were both -0.073 RMB, down from 0.193 RMB in Q3 2021[33]. - The company reported a total comprehensive income attributable to the parent company of -48,445,684.05 RMB in Q3 2022, compared to 128,127,360.23 RMB in Q3 2021[33]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,108,268,268.92, down 2.86% from the end of the previous year[5]. - Total assets as of September 30, 2022, were CNY 2,108,268,268.92, down from CNY 2,170,369,575.48 at the end of 2021[29]. - Total liabilities as of September 30, 2022, were CNY 908,609,501.76, slightly down from CNY 908,978,819.14 at the end of 2021[29]. - Shareholders' equity decreased to CNY 1,199,658,767.16 from CNY 1,261,390,756.34, a decline of 4.9%[29]. Cash Flow - The cash flow from operating activities for the year-to-date period was ¥46,012,757.30, showing a slight increase of 1.96% year-on-year[4]. - Cash flow from operating activities for the first nine months of 2022 was 46,012,757.30 RMB, slightly up from 45,126,963.65 RMB in the same period of 2021[34]. - Cash inflow from investment activities in Q3 2022 totaled 37,331,344.39 RMB, a decrease from 339,765,644.89 RMB in Q3 2021[35]. - The net cash flow from financing activities in Q3 2022 was -66,018,187.45 RMB, compared to a positive cash flow of 165,855,362.28 RMB in Q3 2021[35]. - The total cash and cash equivalents at the end of Q3 2022 were 937,215,236.61 RMB, down from 741,738,443.79 RMB at the end of Q3 2021[35]. Shareholder Information - The company had a total of 31,907 common shareholders at the end of the reporting period[10]. - The largest shareholder, Hangzhou Zhefa Yilian Business Management Partnership, holds 180,468,652 shares, accounting for 26.83% of total shares, with 127,500,000 shares pledged[11]. Strategic Decisions - The company plans to invest 150 million RMB in its wholly-owned subsidiary, which has been renamed to Shanghai Yilian Green Energy Business Consulting Co., Ltd., to engage in carbon reduction projects[13]. - The company has decided to abandon its transition to the healthcare sector and has returned land use rights for a 106,625 square meter plot, receiving a compensation of 40.73 million RMB[14]. - The company terminated its investment in the biomedical industry base and the non-public offering of A-shares due to changes in the internal and external environment[15]. - The company intended to acquire at least 30% of Shanghai Baochar New Energy Environmental Technology Co., Ltd., with an estimated valuation of no less than 450 million RMB, but ultimately decided to terminate the acquisition[17]. - The company approved the transfer of assets from its wholly-owned subsidiary Zhejiang Foreign Trade to Shanghai Haiyouwei New Materials Co., Ltd. for a total price of 218 million RMB (including tax) on September 27, 2022[18]. Incentive Plans - The company granted 1.7 million restricted stock units to an incentive object at a price of 3.23 RMB per share, increasing the total number of shares from 671,053,072 to 672,753,072[19]. - The company adjusted the performance assessment requirements and the assessment years for its 2021 restricted stock incentive plan, now covering 2021, 2023, and 2024[20]. - The first unlock period for the 2021 restricted stock incentive plan was achieved, allowing for the release of 2.49 million shares[21]. - The company announced a plan for key executives to increase their shareholdings by at least 50 million RMB, with specific amounts designated for each individual[22]. - The shareholding increase plan was extended by six months due to the impact of COVID-19 and other factors, now set to conclude on April 26, 2023[23]. Legal Matters - The company faced legal challenges regarding rental income claims, with courts ruling in favor of the company in multiple cases[24][25][26]. Operational Metrics - Total operating costs for the first three quarters of 2022 were CNY 407,510,258.31, down 33.8% from CNY 615,398,126.25 in 2021[31]. - Research and development expenses for the first three quarters of 2022 were CNY 3,123,124.82, down 53.3% from CNY 6,690,179.00 in the same period of 2021[31]. - Cash and cash equivalents as of September 30, 2022, were CNY 937,215,236.61, slightly down from CNY 948,672,786.31 at the end of 2021[28]. - Accounts receivable increased to CNY 165,007,742.48 as of September 30, 2022, from CNY 136,323,602.50 at the end of 2021, representing a growth of 21.1%[28]. - Inventory decreased to CNY 89,548,067.33 from CNY 98,263,399.04, a decline of 8.7%[28].